Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-10-13 Sale | 2021-10-13 8:24 pm | SpringWorks Therapeutics Inc. | SWTX | Smith L. Mary Chief Development Officer | 10,000 | $55.97 | $559,675 | 251,807 (Direct) | View |
| 2021-07-13 Sale | 2021-07-14 4:28 pm | SpringWorks Therapeutics Inc. | SWTX | Smith L. Mary Chief Development Officer | 10,000 | $80.88 | $808,777 | 261,807 (Direct) | View |
| 2021-04-13 Sale | 2021-04-13 8:21 pm | SpringWorks Therapeutics Inc. | SWTX | Smith L. Mary Chief Development Officer | 10,000 | $68.07 | $680,723 | 271,807 (Direct) | View |
| 2021-01-20 Sale | 2021-01-21 4:31 pm | SpringWorks Therapeutics Inc. | SWTX | Smith L. Mary Chief Development Officer | 10,000 | $78.7 | $787,016 | 283,258 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-01-08 Tax Withholding | 2024-01-08 9:13 pm | N/A N/A | SpringWorks Therapeutics Inc. | SWTX | Smith L. Mary Chief Development Officer | 3,535 | $41.53 | 293,363 (Direct) | View |
| 2024-01-04 Option Award | 2024-01-08 9:13 pm | N/A 2034-01-03 | SpringWorks Therapeutics Inc. | SWTX | Smith L. Mary Chief Development Officer | 81,156 | $0 | 293,363 (Direct) | View |
| 2024-01-05 Tax Withholding | 2024-01-08 9:13 pm | N/A N/A | SpringWorks Therapeutics Inc. | SWTX | Smith L. Mary Chief Development Officer | 2,197 | $37.96 | 293,363 (Direct) | View |
| 2023-06-30 Option Award | 2023-07-05 4:06 pm | N/A N/A | SpringWorks Therapeutics Inc. | SWTX | Smith L. Mary Chief Development Officer | 5,720 | $0 | 217,939 (Direct) | View |
| 2023-01-07 Tax Withholding | 2023-01-10 4:01 pm | N/A N/A | SpringWorks Therapeutics Inc. | SWTX | Smith L. Mary Chief Development Officer | 1,068 | $26.41 | 212,219 (Direct) | View |
| 2023-01-05 Option Award | 2023-01-09 5:00 pm | N/A 2033-01-05 | SpringWorks Therapeutics Inc. | SWTX | Smith L. Mary Chief Development Officer | 157,663 | $0 | 348,287 (Direct) | View |
| 2023-01-06 Tax Withholding | 2023-01-09 5:00 pm | N/A N/A | SpringWorks Therapeutics Inc. | SWTX | Smith L. Mary Chief Development Officer | 2,452 | $27.52 | 348,287 (Direct) | View |
| 2022-07-18 Tax Withholding | 2022-07-20 6:02 pm | N/A N/A | SpringWorks Therapeutics Inc. | SWTX | Smith L. Mary Chief Development Officer | 1,551 | $28.47 | 193,076 (Direct) | View |
| 2022-06-30 Option Award | 2022-07-05 5:30 pm | N/A N/A | SpringWorks Therapeutics Inc. | SWTX | Smith L. Mary Chief Development Officer | 6,092 | $0 | 194,627 (Direct) | View |
| 2022-01-07 Tax Withholding(A) | 2022-01-14 4:58 pm | N/A N/A | SpringWorks Therapeutics Inc. | SWTX | Smith L. Mary Chief Development Officer | 1,181 | $56.06 | 188,535 (Direct) | View |
| 2022-01-07 Tax Withholding | 2022-01-11 4:03 pm | N/A N/A | SpringWorks Therapeutics Inc. | SWTX | Smith L. Mary Chief Development Officer | 1,772 | $56.06 | 187,944 (Direct) | View |
| 2022-01-06 Option Award | 2022-01-10 4:25 pm | N/A 2032-01-06 | SpringWorks Therapeutics Inc. | SWTX | Smith L. Mary Chief Development Officer | 91,412 | $0 | 258,923 (Direct) | View |
| 2021-10-13 Exercise | 2021-10-13 8:24 pm | N/A 2029-04-22 | SpringWorks Therapeutics Inc. | SWTX | Smith L. Mary Chief Development Officer | 10,000 | $0 | 251,807 (Direct) | View |
| 2021-10-13 Exercise | 2021-10-13 8:24 pm | N/A N/A | SpringWorks Therapeutics Inc. | SWTX | Smith L. Mary Chief Development Officer | 10,000 | $2.3 | 251,807 (Direct) | View |
| 2021-07-13 Exercise | 2021-07-14 4:28 pm | N/A 2029-04-22 | SpringWorks Therapeutics Inc. | SWTX | Smith L. Mary Chief Development Officer | 10,000 | $0 | 261,807 (Direct) | View |
| 2021-07-13 Exercise | 2021-07-14 4:28 pm | N/A N/A | SpringWorks Therapeutics Inc. | SWTX | Smith L. Mary Chief Development Officer | 10,000 | $2.3 | 261,807 (Direct) | View |
| 2021-04-13 Exercise | 2021-04-13 8:21 pm | N/A 2029-04-22 | SpringWorks Therapeutics Inc. | SWTX | Smith L. Mary Chief Development Officer | 10,000 | $0 | 271,807 (Direct) | View |
| 2021-04-13 Exercise | 2021-04-13 8:21 pm | N/A N/A | SpringWorks Therapeutics Inc. | SWTX | Smith L. Mary Chief Development Officer | 10,000 | $2.3 | 271,807 (Direct) | View |
| 2021-01-20 Exercise | 2021-01-21 4:31 pm | N/A 2029-03-19 | SpringWorks Therapeutics Inc. | SWTX | Smith L. Mary Chief Development Officer | 10,000 | $0 | 283,258 (Direct) | View |
| 2021-01-20 Exercise | 2021-01-21 4:31 pm | N/A N/A | SpringWorks Therapeutics Inc. | SWTX | Smith L. Mary Chief Development Officer | 1,128 | $1.65 | 283,258 (Direct) | View |
| 2021-01-20 Exercise | 2021-01-21 4:31 pm | N/A N/A | SpringWorks Therapeutics Inc. | SWTX | Smith L. Mary Chief Development Officer | 8,872 | $2.3 | 283,258 (Direct) | View |
| 2021-01-07 Option Award | 2021-01-11 09:30 am | N/A 2031-01-07 | SpringWorks Therapeutics Inc. | SWTX | Smith L. Mary Chief Development Officer | 99,000 | $0 | 255,511 (Direct) | View |
| 2020-03-02 Option Award | 2020-03-04 6:22 pm | N/A 2030-03-02 | SpringWorks Therapeutics Inc. | SWTX | Smith L. Mary See Remarks | 75,000 | $0 | 75,000 (Direct) | View |